Delivery Order SPE2DB22D3004-SPE2DB26FQ72C
Award Date 10/23/25
Potential Completion Date 10/24/25
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,525.20 delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pen (0.5 ml), a GLP-1 receptor agonist medication used for weight management. This firm fixed-price, competitively awarded delivery order was issued on September 3, 2025, with an ultimate completion date of September 4, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,234.96 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen (0.5ml), a GLP-1 receptor agonist medication used for weight management. The contract is a firm fixed-price delivery order with no set-aside designation, awarded on August 26, 2025, with an ultimate completion date of August 27, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $28,634.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors on August 11, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999, which runs through December 2026. The performance location is the company's corporate office in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency awarded a $11,086.64 delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 mL pen injectors (0.5 mL), a GLP-1 receptor agonist medication used for weight management. This firm fixed price, non-set-aside contract was awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $42,553.88 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens, a GLP-1 receptor agonist medication used for weight management and diabetes treatment. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,906.47 for Zepbound 2.5 mg/0.5 ml pen (0.5 ml), a GLP-1 receptor agonist medication used for weight management. This firm fixed-price, competitively awarded delivery order is scheduled for completion by August 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a $9,725.21 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens, a GLP-1 receptor agonist medication used in diabetes and weight management treatment. This firm fixed-price, competitively awarded delivery order is set to be completed by August 7, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $7,218.52 delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 ml pen injections (0.5 ml), a GLP-1 receptor agonist medication used for weight management. The contract, executed on August 26, 2025, with completion targeted for August 27, 2025, utilizes firm fixed-price pricing under a non-set-aside competitive procurement. Performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a $2,831.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 mL pen injections on August 8, 2025, with an ultimate completion date of August 11, 2025. This non-set-aside contract represents a small-value transaction for the supply of this GLP-1 receptor agonist medication used in weight management and metabolic health treatment. The delivery order is being performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $12,202.52 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on September 5, 2025, with a completion date of September 8, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion contract vehicle...